Fecal Calprotectin Levels Could Be Used as a Predictor of Endoscopic Remission for Inflammatory Bowel Disease Patients: Taiwan Society of Inflammatory Bowel Disease Multicenter Study

被引：1
|
作者：
Lin, Wei-Chen
Wong, Jau-Min
Lin, Ching-Pin
Chou, Jen-Wei
Wang, Horng-Yuan
Shieh, Ming-Jium
Chang, Chin-Hao
Liu, Heng-Hsiu
Wei, Shu-Chen
机构：
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2015年 / 13卷 / 07期
关键词：
D O I：
10.1016/j.cgh.2015.04.106
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E101 / E101
页数：1
相关论文
共 50 条
  • [21] Fecal NGAL and Fecal Calprotectin in Inflammatory Bowel Disease Diagnosis
    Mukhametova, Dilyara
    Abdulganieva, Diana
    Valeeva, Ildariya
    Abdulhakov, Sayar
    Odintsova, Alfiya
    INFLAMMATORY BOWEL DISEASES, 2016, 22 : S45 - S45
  • [22] Fecal Calprotectin as a Screening Marker for Inflammatory Bowel Disease
    Sridhar, Mathrubootham
    Kesavelu, Dhanasekhar
    INDIAN PEDIATRICS, 2019, 56 (03) : 249 - 250
  • [23] A Functional Medicine Program for Patients With Inflammatory Bowel Disease and Improvement in Fecal Calprotectin Levels
    Strobel, Thomas M.
    Spring, Emily
    Horst, Sara
    Campbell, Sarah
    Robbins, Randi
    Dalal, Robin
    Scoville, Elizabeth
    Pabla, Baldeep
    Schwartz, David
    Beaulieu, Dawn Borromeo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S2156 - S2157
  • [24] Not All Fecal Calprotectin is Specific for Inflammatory Bowel Disease
    Iana, Gueorguieva
    Randall, Jacobs
    Marc, Piper
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S5 - S5
  • [25] Fecal calprotectin: a new marker of inflammatory bowel disease
    Merlotti, Claudia
    Dolci, Alberto
    Scapellato, Luisa
    Panteghini, Mauro
    BIOCHIMICA CLINICA, 2005, 29 (5-6) : 507 - 514
  • [26] QUALITY OF LIFE, FECAL CALPROTECTIN AND ENDOSCOPIC DISEASE ACTIVITY: A STUDY OF CORRELATION IN INFLAMMATORY BOWEL DISEASE.
    Magalhaes, Rui S.
    Xavier, Sofia
    de Castro, Francisca Dias
    Goncalves, Tiago Curdia
    Rosa, Bruno
    Moreira, Maria Joao
    Cotter, Jose
    GASTROENTEROLOGY, 2020, 158 (06) : S656 - S656
  • [27] Fecal Calprotectin as Predictor of Relapse in Patients With Inflammatory Bowel Disease Under Maintenance Infliximab Therapy
    Ferreiro-Iglesias, Rocio
    Barreiro-de Acosta, Manuel
    Otero Santiago, Manuel
    Lorenzo Gonzalez, Aurelio
    Alonso de la Pena, Carmen
    Benitez Estevez, Alfonso J.
    Enrique Dominguez-Munoz, Juan
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2016, 50 (02) : 147 - 151
  • [28] Compliance With Fecal Calprotectin Testing in Pediatric Patients With Inflammatory Bowel Disease
    Queliza, Karen
    Wang, Michael K.
    Kellermayer, Richard
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2018, 66 (06): : 932 - 933
  • [29] Standardizing Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease
    Park, K. T.
    Heida, Anke
    van Rheenen, Patrick F.
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (09) : E47 - E47
  • [30] Low Fecal Calprotectin Predicts Sustained Clinical Remission in Inflammatory Bowel Disease Patients: A Plea for Deep Remission
    Mooiweer, Erik
    Severs, Mirjam
    Schipper, Marguerite E. I.
    Fidder, Herma H.
    Siersema, Peter D.
    Laheij, Robert J. F.
    Oldenburg, Bas
    JOURNAL OF CROHNS & COLITIS, 2015, 9 (01): : 50 - 55
12345